Innovative medical technology from Bochum: High-Tech Gründerfonds and enjoyventure invest in amedo smart tracking solutions GmbH

July 17, 2008

The team of amedo smart tracking solutions GmbH is highly appreciating the investment of the High-Tech Gründerfonds and the ELS fund managed by enjoyventure.

“Now we can finally realize a technology platform which enables, similar to GPS, the wireless, sub-millimeter precise localisation and tracking for all types of minimally invasive surgical instruments,” stresses Volker Trösken, CEO of the young company with headquarters in Bochum Technology Centre.

Currently existing real time location systems usually provide a maximum accuracy in the meter range; under favourable conditions the accuracy is 30 cm. The team of amedo STS and its CTO Laszlo Hasenau are convinced to reach a sub-millimeter precise localisation – a quantum leap in wireless radio positioning.

amedo smart tracking solutions GmbH, founded in April 2008 being 2nd place winner of the Life Science Business Plan Competition “Startbahn Ruhr”, is developing a transponder-based tracking technology and a product family of trackable instruments & tools for image guided minimally invasive interventions. The market approvals are already obtained for Europe and the US for the first generation of trackable needles for biopsy, vertebroplasty and tumor therapy.

Currently, the main areas of application for medical tracking are in the hip or knee – endoprothetics, the spinal interventions, the craniofacial surgery or biopsy. The wireless cross-technology of amedo STS will revolutionize medical navigation and also will allow applications in areas for which existing tracking systems are not available today, as for example flexible instruments for cardiologic, neuroradiologic and other interventional procedures such as the soft tissue surgery.

“The cross-cutting tracking technology of amedo smart tracking solutions enables the penetration of new markets even outside the medical technology and leads to a very scalable business model. Convincing for us is that the implementation of the business concept lays in the responsibility of a complementary and well-experienced team in VC and exit” says Wolfgang Lubert, managing director of enjoyventure, commenting on the investment decision of his house.

Dr. Bernd Goergen, investment manager of the High-Tech Gründerfonds: “at amedo smart tracking solutions, everything just fits perfectly together: a technology which really could revolutionize navigated surgery, a competent and sector-experienced management team and well established relationships into the clinical community. I have great confidence in the future development of this investment. ”

Contact:
amedo smart tracking solutions GmbH
Dipl.-Ing. Volker Trösken
Dipl.-Betriebsw. Gunnar Mohnhaupt
Universitätsstr. 142
44799 Bochum
Germany
Tel.: +49-234-97072-0
Fax: +49–234-97072-670
E-Mail: info@amedo-gmbh.com
Web: www.amedo-gmbh.com

About enjoyventure:
enjoyventure is a privately held investment manager, focused on early stage investments in the seed and start-up phase, as well as further funding in the development phase. enjoyventure insvests in technology driven companies, especially in the fields of selected IT / software solutions, nano / micro-system technology, production & automatisation techniques, medical technology, and telecommunications. Enjoyventure has special expertise in the structuring and funding of spin-off‘s from corporations and technical-scientific institutions.

Active coaching, intensive contacts and network management, as well as monitoring belong to the self-understanding of enjoyventure as industrial adviser and investor. The partners of enjoyventure combine entrepreneurial, financial and industrial expertise as well and associated networks. Since its foundation in January 2000 enjoyventure has invested in in 16 companies. To date, enjoyventure manages three venture capital funds with a total volume of approx. € 40 million.

Contact:
enjoyventure Management GmbH
Mr. Wolfgang Lubert

Office Düsseldorf
GAP 15
(TCH)
Graf-Adolf-Platz 15
40213 Düsseldorf
Tel. +49 (0211) 239 551 70
Fax +49 (0211) 239 551 77

Main-Office Gelsenkirchen
Zeche Holland
Ückendorfer Strasse 237e
45886 Gelsenkirchen
Tel. +49 (0209) 957 185 00
Fax +49 (0209) 957 185 07

Office Hannover
Technologie-Centrum Hannover
Vahrenwalder Straße 7
30165 Hannover
Tel. +49 (0511) 300 333-22
Fax +49 (0511) 300 333-99

office@enjoyventure.de
www.enjoyventure.de

About ELS Fund:
ELS Fonds GmbH & Co. KG is a regional seed fund, initiated by the NRW.Bank and the local saving banks of Gelsenkirchen and Recklinghausen. Further institutional investors as well as a group of industrial entrepreneurs of the region have joined the fund as further investors. The total fund size is approximately € 12.5 millions.
ELS fund focuses on early-stage investments in technology driven companies in the fields of energy, health care, chemistry and associated system-, production-, IT- and surface technologies, which have a seat or principal place of business in the upper Ruhr or lower Rhein area.
The ELS fund is managed by enjoyventure.

About the High-Tech Gründerfonds:
The High-Tech Gründerfonds invests venture capital in young technology companies that transform promising scientific research into business enterprises. The seed financing of up to 500 T€ shall result in a technical prototype, a proof of concept or a proof of market. High-Tech Gründerfonds has access to a fund volume of around 272.0 million Euro. Investors in this public-private partnership include the Federal Ministry for Economy and Technology, the KfW Banking Group as well as the six industry companies BASF, Robert Bosch, Carl Zeiss, Daimler, Deutsche Telekom and Siemens.

Contact:
Dr. Bernd Goergen
High-Tech Gründerfonds Management GmbH
Ludwig-Erhard-Allee 2
53175 Bonn
Tel.: 0228 / 965685-00
Fax: 0228 / 965685-50
info@high-tech-gruenderfonds.de
www.high-tech-gruenderfonds.de

Stay up to date

Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!

Press
8. October 2024

Lymphatica Medtech closes €17.9M Series B funding round to drive Innovation in Lymphedema Treatment

Lausanne, October 8th, 2024 – Lymphatica Medtech SA, a clinical-stage company based in Lausanne, Switzerland, specialized in innovative treatments for lymphedema, has raised €17.9 million in Series B funding. This investment will accelerate the clinical development and validation of LymphoDrain, a breakthrough implantable device designed to treat lymphedema, a chronic vascular condition that currently has no cure and affects millions worldwide. First of its kind, LymphoDrain is easy to i
 
Press
26. September 2024


HTGF takes a stand for diversity: Signing of the Charta der Vielfalt

Bonn, 26 September 2024 – The High-Tech Gründerfonds (HTGF), one of the leading and most active early-stage investors in Germany and Europe, signs the Charta der Vielfalt (Diversity Charter) and thus visibly commits itself to a respectful and prejudice-free working environment, both towards its employees and within the start-up ecosystem. The Diversity Charter is an initiative to promote diversity in companies and institutions under the patronage of German Chancellor Olaf Schol